Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Horizon Therapeutics)"
Count: 39
Selected: 0
| NCT ID | Title |
|---|
| NCT04948099 | A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases | ||
| NCT04925934 | Study of VIB7734 for the Treatment of Moderate to Severely Active SLE | ||
| NCT04540497 | A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease | ||
| NCT04524273 | Myasthenia Gravis Inebilizumab Trial | ||
| NCT04163991 | A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis | ||
| NCT04129164 | A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome | ||
| NCT04046549 | A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant | ||
| NCT03335488 | Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs) | ||
| NCT02246218 | A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders | ||
| NCT01948427 | Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs) | ||
| NCT01257737 | To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs) | ||
| NCT05909761 | Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy | ||
| NCT05669014 | A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) | ||
| NCT05591222 | Study of Daxdilimab (HZN-7734) in Patients With Moderate-to-Severe Primary Discoid Lupus Erythematosus | ||
| NCT05565768 | Study to Evaluate HZN-457 in Healthy Volunteers | ||
| NCT05549258 | Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder | ||
| NCT05540665 | Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) | ||
| NCT05430854 | Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study | ||
| NCT05368103 | Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata | ||
| NCT05032066 | A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT04781543 | A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis | ||
| NCT04772313 | Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Failed Pegloticase Monotherapy | ||
| NCT04762498 | A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) | ||
| NCT04511702 | Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate | ||
| NCT04087720 | Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant | ||
| NCT03994731 | Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout | ||
| NCT03635957 | Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout | ||
| NCT05002998 | TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study | ||
| NCT04583735 | A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease | ||
| NCT04478994 | A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) | ||
| NCT04526912 | Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection | ||
| NCT04174677 | Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor | ||
| NCT03817424 | A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis | ||
| NCT03621605 | A Phase1 Study of VIB9600 | ||
| NCT02780674 | A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases | ||
| NCT02780388 | A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis | ||
| NCT04937062 | Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy | ||
| NCT02464501 | The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee | ||
| NCT02395744 | The COPPER-B Trial |
